Weiss Multi-Strategy Advisers’s Esperion Therapeutics ESPR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,493	Closed	-$350K	–	710
2021 Q1	$350K	Sell	12,493 -1,526	-11%	-$45K	0.01%	585
2020 Q4	$364K	Buy	14,019 +928	+7%	+$27.8K	0.01%	609
2020 Q3	$487K	Buy	13,091 +6,091	+87%	+$241K	0.01%	481
2020 Q2	$359K	Buy	+7,000	New	+$293K	0.01%	488
2016 Q2	–	Sell	-16,000	Closed	-$271K	–	434
2016 Q1	$271K	Hold	16,000	–	–	0.01%	417
2015 Q4	$356K	Buy	16,000 +6,000	+60%	+$151K	0.02%	321
2015 Q3	$236K	Sell	10,000 -15,000	-60%	-$941K	0.01%	364
2015 Q2	$2.04M	Sell	25,000 -5,000	-17%	-$489K	0.08%	239
2015 Q1	$2.78M	Sell	30,000 -10,000	-25%	-$645K	0.12%	202
2014 Q4	$1.62M	Buy	40,000 +10,000	+33%	+$306K	0.06%	240
2014 Q3	$734K	Hold	30,000	–	–	0.02%	410
2014 Q2	$475K	Hold	30,000	–	–	0.01%	526
2014 Q1	$454K	Sell	30,000 -30,000	-50%	-$466K	0.01%	690
2013 Q4	$824K	Sell	60,000 -40,000	-40%	-$582K	0.02%	479
2013 Q3	$1.89M	Buy	+100,000	New	+$1.68M	0.04%	348

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ESPR Position: Q2 2021 in Review

Weiss Multi-Strategy Advisers sold out of Esperion Therapeutics (ESPR) in Q2 2021, closing a stake of 12,493 shares — an estimated $350K sold.

Weiss Multi-Strategy Advisers first reported a position in ESPR in Q3 2013 and held it in 15 quarters. The position peaked at $2.78M in Q1 2015. 142 funds tracked by Wall St. Rank hold ESPR as of Q2 2021.

Weiss Multi-Strategy Advisers reported no remaining Esperion Therapeutics position as of Q2 2021 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 12,493 Esperion Therapeutics shares in Q2 2021, an estimated $350K.
Weiss Multi-Strategy Advisers first reported a position in Esperion Therapeutics in Q3 2013 and held it in 15 quarters.
Weiss Multi-Strategy Advisers's Esperion Therapeutics position peaked at $2.78M in Q1 2015.
142 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.